Clear Eyes Redness Relief Recalled for Lack of Sterility Assurance
Altaire Pharmaceuticals is recalling Clear Eyes Redness Relief eye drops due to a lack of assurance of sterility. Consumers should stop using the product.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury or hospitalization reports are rated as Severe (4). While the source does not explicitly state hospitalizations, the lack of sterility assurance in an ophthalmic product poses a significant risk of serious injury, aligning with the Severe criteria for Class II recalls with potential for significant harm.
Plain-English summary
Altaire Pharmaceuticals, Inc. is recalling Clear Eyes Redness Relief eye drops, 15 mL bottles, due to a lack of assurance of sterility. The affected products are identified by the following lot numbers and expiration dates: Lot 16195 (Exp 7/19), Lot 16211 (Exp 8/19), and Lot 16216 (Exp 8/19). The product is identified by UPC 6-78112-25415-6.
The recall was initiated because the manufacturer could not ensure the sterility of the product. The source text does not specify the number of units recalled or report any specific illnesses or injuries associated with the use of these products.
Consumers who have purchased these specific lots of Clear Eyes Redness Relief should stop using the product immediately. The source text does not provide specific instructions for disposal or return, but consumers should consult the manufacturer or a healthcare professional for guidance.
The recalled product
- Product
- Clear Eyes Redness Relief, Product Size: 15 mL, UPC#: 6-78112-25415-6
- Manufacturer
- Altaire Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: 16195
- Exp 7/19
- 16211
- Exp 8/19
- 16216
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 134 recalled by Altaire Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 134 products in this recall →Related recalls
Same manufacturer · Altaire Pharmaceuticals, Inc.
See all →- SevereCVS Health Dry Eye Relief Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls Equate Support Advanced Twin Pack Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls OCuSOFT Ophthalmic Ointment Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22